|
GB202018901D0
|
|
New pharmaceutical composition
|
|
GB202009905D0
|
|
New pharmaceutical composition
|
|
US10729687B1
|
|
Pharmaceutical composition for nasal delivery
|
|
US10653690B1
|
|
Pharmaceutical composition for nasal delivery
|
|
GB201904783D0
|
|
New pharmaceutical compositions
|
|
GB201904771D0
|
|
New pharmaceutical compositions
|
|
GB201904767D0
|
|
New pharmaceutical compositions
|
|
GB201904785D0
|
|
New pharmaceutical compositions
|
|
WO2019064026A1
|
|
New pharmaceutical compositions
|
|
GB201810261D0
|
|
New pharmaceutical compositions
|
|
GB201810265D0
|
|
New pharmaceutical compositions
|
|
GB201715881D0
|
|
New pharmaceutical compositions
|
|
AU2013245546A1
|
|
New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
|
|
WO2013164617A1
|
|
New sufentanil composition for the treatment of acute pain
|
|
BR112014027213A2
|
|
New Alfentanil Composition for Acute Pain Treatment
|
|
GB201304625D0
|
|
New pharmaceutical composition
|
|
GB201221130D0
|
|
New pharmaceutical composition
|
|
WO2013041851A1
|
|
New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
|
|
GB201207701D0
|
|
New pharmaceutical composition
|
|
GB201207628D0
|
|
New pharmaceutical composition
|
